AstraZeneca signs partnership of Foxiga and Xigduo with Daewoong Pharmaceutical
AstraZeneca Korea(CEO/President Sang-Pyo Kim) announced the company established a distribution partnership of ‘Forxiga(dapagliflozin)’ and ‘Xigduo(dapagliflozin/metformin),’ SGLT-2 inhibitors for the treatment of hepatitis type 2, with Daewoong Pharmaceutical(CEO Jong-Wook Lee).
Therefore, Daewo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
